Protalix Biotherapeutics, Inc. (PLX)
2.055
0.00 (0.00%)
USD |
NYAM |
Jan 15, 16:00
2.055
0.00 (0.00%)
After-Hours: 20:00
Protalix Biotherapeutics SG&A Expense (TTM): 11.16M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| OraSure Technologies, Inc. | 77.29M |
| PAVmed, Inc. | 16.57M |
| Denali Therapeutics, Inc. | 127.16M |
| AIM ImmunoTech, Inc. | 10.06M |
| Armata Pharmaceuticals, Inc. | 12.31M |